Medicine and Dentistry
Acute Graft Versus Host Disease
25%
Allogeneic Hematopoietic Stem Cell Transplantation
62%
Bone Marrow Transplantation
12%
Cell Transplantation
100%
Chronic Graft Versus Host Disease
25%
Comorbidity
12%
Conditioning
25%
COVID-19
12%
Cryopreservation
100%
Cyclophosphamide
100%
Diagnosis
12%
Disease
25%
Disease Free Survival
25%
Graft Versus Host Reaction
100%
Hazard Ratio
100%
Hematologic Malignancy
25%
Hematopoietic Cell
100%
Infusion
12%
Karnofsky Performance Status
25%
Logistic Regression Analysis
12%
Neutrophil
12%
Non-Relapse Mortality
37%
Overall Survival
100%
Peripheral Blood Stem Cell
12%
Platelet
12%
Progression Free Survival
12%
Prophylaxis
100%
Transplantation
12%
Transplantation Conditioning
12%
Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Bone Marrow Graft
7%
Cell Collection
7%
Cell Grafting
7%
Comorbidity Index
7%
Conditioning Intensity
7%
Conditioning Regimen
7%
Confidence Interval
100%
COVID-19 Pandemic
7%
Cryopreservation
100%
Cryopreserved
23%
Cryopreserved Graft
38%
Disease Diagnosis
7%
Disease Risk Prediction
15%
Disease-free Survival
15%
Donor Cells
7%
Donor Evaluation
7%
Donor Graft
7%
Donor Type
7%
Donor-recipient Matching
7%
Graft Source
7%
Graft Type
7%
Graft-versus-host Disease (GvHD)
30%
Graft-versus-host Disease Prophylaxis
100%
Hazard Ratio
61%
Hematological Malignancies
15%
Hematopoietic Recovery
7%
High Risk
7%
Histology
7%
Karnofsky Performance Status
15%
Logistic Regression
7%
Low Dose Rate
7%
Marrow Transplantation
7%
Mortality Hazard
15%
Mortality Risk
7%
Multiple Comparisons
15%
Neutrophil Recovery
7%
Non-associated
7%
Non-relapse Mortality
23%
Overall Survival
100%
P-12
7%
P-27
7%
P-32
7%
Peripheral Blood Stem Cell Graft
7%
Platelet Recovery
7%
Post-transplantation Cyclophosphamide (PTCy)
100%
Pretransplant
7%
Progression-free Survival
7%
Propensity Score
15%
Recovery Increase
7%
Regression Analysis
7%
Risk Index
7%
Risk Propensity
7%
Source Intensity
7%
Statistical Significance
7%
Treatment Failure
7%
Nursing and Health Professions
Acute Graft Versus Host Disease
15%
Allogeneic Hematopoietic Stem Cell Transplantation
38%
Bone Marrow Transplantation
7%
Cell Transplantation
100%
Chronic Graft Versus Host Disease
15%
Comorbidity
7%
Confidence Interval
100%
Cryopreservation
100%
Cyclophosphamide
100%
Diagnosis
7%
Disease
15%
Disease Free Survival
15%
Graft Versus Host Reaction
100%
Hazard Ratio
61%
Hematologic Malignancy
15%
Infusion
7%
Karnofsky Performance Status
15%
Logistic Regression Analysis
7%
Overall Survival
100%
Pandemic
7%
Progression Free Survival
7%
Propensity Score
15%
Prophylaxis
100%
Transplantation
7%
Transplantation Conditioning
7%
Treatment Failure
7%
Immunology and Microbiology
Acute Graft Versus Host Disease
33%
Allogeneic Hematopoietic Stem Cell Transplantation
83%
Cell Transplantation
100%
Chronic Graft Versus Host Disease
33%
Comorbidity
16%
Conditioning
50%
COVID-19
16%
Cryopreservation
100%
Cyclophosphamide
100%
Disease Free Survival
33%
Graft-Versus-Host Disease
100%
Hematopoietic Cell
100%
Neutrophil
16%
Overall Survival
100%
Peripheral Blood Stem Cell
16%
Platelet
16%
Progression Free Survival
16%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Graft Versus Host Disease
33%
Chronic Graft Versus Host Disease
33%
Comorbidity
16%
Cyclophosphamide
100%
Disease
50%
Disease Free Survival
33%
Graft Versus Host Reaction
100%
Hematologic Malignancy
33%
Overall Survival
100%
Pandemic
16%
Progression Free Survival
16%
Neuroscience
Comorbidity
16%
Cyclophosphamide
100%
Hematopoietic Cell
100%
Platelet
16%
Stem Cell
16%